[CYCC] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
29-Apr-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 13.55%
YoY- 28.95%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 10 4 29 31 16 373 0 -
PBT -2,167 -3,669 -7,225 -6,093 -6,699 -6,034 -7,124 -54.67%
Tax -210 -412 -4,279 -822 -602 -586 -1,320 -70.54%
NP -2 -3,257 -2,946 -5,271 -6,097 -5,448 -5,804 -99.50%
Tax Rate - - - - - - - -
Total Cost 12 3,261 2,975 5,302 6,113 5,821 5,804 -98.35%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -19.57 -81,425.00 -10,158.62 -17,003.23 -38,106.25 -1,460.59 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.00 -1.80 -2.27 -6.17 -7.23 -6.51 -6.94 -
EPS Diluted -0.00 -1.80 -2.27 -6.17 -7.23 -6.51 -6.94 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.